Studienserver - Medizinische Hochschule Hannover

Studies: Budesonide in oral chronic GvHD

ID Trial

EudraCT number

Clinicaltrials.gov identifier

Description

Double-blind, randomised, placebo-controlled multicentre phase III clinical study followed by open-label phase on the efficacy and tolerability of budesonide 3 mg effervescent tablet in patients with resistant oral chronic GvHD

Status